Ocugen, Inc. Announces First Patient Dosed in Phase 1 Clinical Trial of OCU200—a Novel Integrin-Targeting Biologic for Diabetic Macular Edema
Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and ...
Arknights: Endfield system requirements
What are the Arknights: Endfield system requirements? With the beloved Arknights world set to expand into the realm of PC ...
Hosted on MSN56m
TSM Stock Jumps As Chip Foundry Tops Q4 Estimates On AI Chip Sales
Taiwan Semiconductor Manufacturing beat analyst estimates for the fourth quarter, thanks to strong sales of AI chips. TSM ...
AMD RX 9070 models spotted at retailers – all they need now is a price to sink Nvidia’s RTX 5070 GPUs
The next-gen mid-range GPU showdown is almost upon us, and we should know soon enough how AMD pitches its RX 9070 cards.
Nvidia analysts are very bullish on the stock. But this holdout defends his cautious view.
Luria is in a fairly rare spot among Wall Street analysts covering Nvidia. Of the 65 tracked by FactSet, 60 have buy-equivalent ratings while the other five are at the equivalent of neutral. The ...
AMD Radeon RX 9070 and 9070 XT deserve “time in spotlight” says team red
AMD representatives have spoken about the Radeon RX 9070 graphics cards, saying people should "stay tuned" ahead of imminent ...